Commonwealth Equity Services’s Genocea Biosciences, Inc. GNCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-40,069
| Closed | -$50K | – | 3864 |
|
|
2022
Q1 | $50K | Buy |
40,069
+8,088
| +25% | +$10.1K | ﹤0.01% | 3581 |
|
|
2021
Q4 | $37K | Buy |
31,981
+10,576
| +49% | +$12.2K | ﹤0.01% | 3562 |
|
|
2021
Q3 | $41K | Buy |
21,405
+700
| +3% | +$1.34K | ﹤0.01% | 3510 |
|
|
2021
Q2 | $48K | Hold |
20,705
| – | – | ﹤0.01% | 3465 |
|
|
2021
Q1 | $56K | Buy |
20,705
+2,784
| +16% | +$7.53K | ﹤0.01% | 3325 |
|
|
2020
Q4 | $43K | Buy |
17,921
+3,900
| +28% | +$9.36K | ﹤0.01% | 3141 |
|
|
2020
Q3 | $32K | Buy |
14,021
+41
| +0.3% | +$94 | ﹤0.01% | 2985 |
|
|
2020
Q2 | $32K | Hold |
13,980
| – | – | ﹤0.01% | 2882 |
|
|
2020
Q1 | $24K | Buy |
+13,980
| New | +$24K | ﹤0.01% | 2747 |
|
|
2019
Q2 | – | Sell |
-2,997
| Closed | -$14K | – | 2850 |
|
|
2019
Q1 | $14K | Sell |
2,997
-125
| -4% | -$584 | ﹤0.01% | 2718 |
|
|
2018
Q4 | $7K | Hold |
3,122
| – | – | ﹤0.01% | 2661 |
|
|
2018
Q3 | $19K | Buy |
3,122
+988
| +46% | +$6.01K | ﹤0.01% | 2748 |
|
|
2018
Q2 | $15K | Buy |
2,134
+31
| +1% | +$218 | ﹤0.01% | 2739 |
|
|
2018
Q1 | $17K | Buy |
+2,103
| New | +$17K | ﹤0.01% | 2670 |
|